Not applicableStudy completedNCT01942213
What this trial is testing
Observational Study to Evaluate and Compare the Rate and Extent of Inflammation After a Single Intravitreal Injection of Ranibizumab vs. a Single Intravitreal Injection of Aflibercept in Treatment Naive and Treatment Experienced Patients.
Who this might be right for
Neovascular Age Related Macular Degeneration
Prism Vision Group 136